• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AXL受体激酶的调节性膜内蛋白水解产生一个定位于癌细胞细胞核的细胞内结构域。

Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells.

作者信息

Lu Yinzhong, Wan Jun, Yang Zhifeng, Lei Xiling, Niu Qi, Jiang Lanxin, Passtoors Willemijn M, Zang Aiping, Fraering Patrick C, Wu Fang

机构信息

Key Laboratory of Systems Biomedicine, Ministry of Education, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.

School of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.

出版信息

FASEB J. 2017 Apr;31(4):1382-1397. doi: 10.1096/fj.201600702R. Epub 2016 Dec 29.

DOI:10.1096/fj.201600702R
PMID:28034848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5349800/
Abstract

Deregulation of the TAM (TYRO3, AXL, and MERTK) family of receptor tyrosine kinases (RTKs) has recently been demonstrated to predominately promote survival and chemoresistance of cancer cells. Intramembrane proteolysis mediated by presenilin/γ-secretase is known to regulate the homeostasis of some RTKs. In the present study, we demonstrate that AXL, but not TYRO3 or MERTK, is efficiently and sequentially cleaved by α- and γ-secretases in various types of cancer cell lines. Proteolytic processing of AXL redirected signaling toward a secretase-mediated pathway, away from the classic, well-known, ligand-dependent canonical RTK signaling pathway. The AXL intracellular domain cleavage product, but not full-length AXL, was further shown to translocate into the nucleus a nuclear localization sequence that harbored a basic HRRKK motif. Of interest, we found that the γ-secretase-uncleavable AXL mutant caused an elevated chemoresistance in non-small-cell lung cancer cells. Altogether, our findings suggest that AXL can undergo sequential processing mediated by various proteases kept in a homeostatic balance. This newly discovered post-translational processing of AXL may provide an explanation for the diverse functions of AXL, especially in the context of drug resistance in cancer cells.-Lu, Y., Wan, J., Yang, Z., Lei, X., Niu, Q., Jiang, L., Passtoors, W. M., Zang, A., Fraering, P. C., Wu, F. Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells.

摘要

受体酪氨酸激酶(RTK)的TAM(TYRO3、AXL和MERTK)家族失调最近被证明主要促进癌细胞的存活和化疗耐药性。已知早老素/γ-分泌酶介导的膜内蛋白水解可调节某些RTK的稳态。在本研究中,我们证明在各种类型的癌细胞系中,AXL可被α-和γ-分泌酶有效且顺序性地切割,而TYRO3或MERTK则不会。AXL的蛋白水解加工将信号导向分泌酶介导的途径,远离经典的、众所周知的配体依赖性经典RTK信号通路。进一步研究表明,AXL细胞内结构域切割产物而非全长AXL会转运至细胞核,其核定位序列包含一个碱性HRRKK基序。有趣的是,我们发现γ-分泌酶不可切割的AXL突变体导致非小细胞肺癌细胞的化疗耐药性升高。总之,我们的研究结果表明,AXL可经历由保持稳态平衡的各种蛋白酶介导的顺序性加工。这种新发现的AXL翻译后加工可能为AXL的多种功能提供解释,尤其是在癌细胞耐药性方面。——卢毅、万军、杨泽、雷雪、牛强、蒋丽、帕斯图尔斯、臧爱、弗雷林、吴峰。AXL受体激酶的调节性膜内蛋白水解产生一个定位于癌细胞核内的细胞内结构域

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/308950459b6f/fasebj201600702Rf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/75a3cc016d1a/fasebj201600702Rf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/008ce55b2063/fasebj201600702Rf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/9f0ffd65dda9/fasebj201600702Rf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/be5ac27f17f9/fasebj201600702Rf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/252ea1676d34/fasebj201600702Rf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/adf57da3fa6b/fasebj201600702Rf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/308950459b6f/fasebj201600702Rf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/75a3cc016d1a/fasebj201600702Rf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/008ce55b2063/fasebj201600702Rf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/9f0ffd65dda9/fasebj201600702Rf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/be5ac27f17f9/fasebj201600702Rf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/252ea1676d34/fasebj201600702Rf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/adf57da3fa6b/fasebj201600702Rf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcc/5349800/308950459b6f/fasebj201600702Rf7.jpg

相似文献

1
Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells.AXL受体激酶的调节性膜内蛋白水解产生一个定位于癌细胞细胞核的细胞内结构域。
FASEB J. 2017 Apr;31(4):1382-1397. doi: 10.1096/fj.201600702R. Epub 2016 Dec 29.
2
Genome-wide screen of gamma-secretase-mediated intramembrane cleavage of receptor tyrosine kinases.γ-分泌酶介导的受体酪氨酸激酶膜内裂解的全基因组筛选。
Mol Biol Cell. 2017 Nov 1;28(22):3123-3131. doi: 10.1091/mbc.E17-04-0261. Epub 2017 Sep 13.
3
Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.木犀草素在非小细胞肺癌细胞中的抗癌作用是通过下调TAM受体酪氨酸激酶介导的,而非白细胞介素-8。
Oncol Rep. 2017 Feb;37(2):1219-1226. doi: 10.3892/or.2016.5336. Epub 2016 Dec 23.
4
Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing.通过ADAM17和γ-分泌酶蛋白水解加工对Mertk表面表达的调控。
Int J Mol Sci. 2024 Apr 17;25(8):4404. doi: 10.3390/ijms25084404.
5
Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.半乳糖凝集素-3 可刺激酪氨酸 3 受体酪氨酸激酶和 Erk 信号转导、细胞存活和人类癌细胞迁移。
Biomolecules. 2020 Jul 11;10(7):1035. doi: 10.3390/biom10071035.
6
Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.不同的TAM受体-配体-磷脂相互作用界定了不同的TAM生物活性。
Elife. 2014 Sep 29;3:e03385. doi: 10.7554/eLife.03385.
7
Gamma-secretase-dependent signaling of receptor tyrosine kinases.γ-分泌酶依赖性受体酪氨酸激酶信号转导。
Oncogene. 2019 Jan;38(2):151-163. doi: 10.1038/s41388-018-0465-z. Epub 2018 Aug 30.
8
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.TAM 家族受体激酶抑制逆转 MDSC 介导的抑制作用,并增强黑色素瘤的抗 PD-1 治疗。
Cancer Immunol Res. 2019 Oct;7(10):1672-1686. doi: 10.1158/2326-6066.CIR-19-0008. Epub 2019 Aug 26.
9
The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.受体酪氨酸激酶AXL促进结直肠癌的迁移和侵袭。
PLoS One. 2017 Jul 20;12(7):e0179979. doi: 10.1371/journal.pone.0179979. eCollection 2017.
10
Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.酪氨酸激酶受体 Tyro3、Axl 和 Mer 受体激酶(Mertk)受体在血小板激活和血栓形成中发挥不同的作用。
Cell Commun Signal. 2018 Dec 12;16(1):98. doi: 10.1186/s12964-018-0308-0.

引用本文的文献

1
Pamoic acid and carbenoxolone specifically inhibit CRISPR/Cas9 in bacteria, mammalian cells, and mice in a DNA topology-specific manner.帕莫酸和甘草次酸以DNA拓扑结构特异性方式在细菌、哺乳动物细胞和小鼠中特异性抑制CRISPR/Cas9。
Genome Biol. 2025 Mar 28;26(1):75. doi: 10.1186/s13059-025-03521-w.
2
Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?自身免疫性疾病和癌症中TAM受体的蛋白水解作用:它向我们传达了什么信息?
Cell Death Dis. 2025 Mar 5;16(1):155. doi: 10.1038/s41419-025-07480-9.
3
MERTK Inhibition as a Targeted Novel Cancer Therapy.

本文引用的文献

1
Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance.受体酪氨酸激酶蛋白水解脱落减少是激酶抑制剂耐药的一种翻译后机制。
Cancer Discov. 2016 Apr;6(4):382-99. doi: 10.1158/2159-8290.CD-15-0933. Epub 2016 Mar 16.
2
Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy.分子通路:AXL,一种治疗抗性的膜受体介导因子。
Clin Cancer Res. 2016 Mar 15;22(6):1313-7. doi: 10.1158/1078-0432.CCR-15-1458. Epub 2016 Jan 13.
3
Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer.
MERTK 抑制作为一种有针对性的新型癌症疗法。
Int J Mol Sci. 2024 Jul 12;25(14):7660. doi: 10.3390/ijms25147660.
4
Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing.通过ADAM17和γ-分泌酶蛋白水解加工对Mertk表面表达的调控。
Int J Mol Sci. 2024 Apr 17;25(8):4404. doi: 10.3390/ijms25084404.
5
Nuclear translocation of Axl contributes to the malignancy of oral cancer cells.Axl的核转位促进口腔癌细胞的恶性程度。
J Dent Sci. 2024 Jan;19(1):438-447. doi: 10.1016/j.jds.2023.08.014. Epub 2023 Aug 29.
6
TAM family kinases as therapeutic targets at the interface of cancer and immunity.酪氨酸激酶家族作为癌症与免疫交叉领域的治疗靶点。
Nat Rev Clin Oncol. 2023 Nov;20(11):755-779. doi: 10.1038/s41571-023-00813-7. Epub 2023 Sep 4.
7
The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer.AXL 受体酪氨酸激酶抑制对卵巢癌细胞 DNA 损伤反应的影响。
Commun Biol. 2023 Jun 22;6(1):660. doi: 10.1038/s42003-023-05045-0.
8
Integrated transcriptomic and metabolomic analysis of cortical neurons reveals dysregulated lipid metabolism, enhanced glycolysis and activated HIF-1 signaling pathways in acute hypoxia.皮质神经元的综合转录组学和代谢组学分析揭示了急性缺氧时脂质代谢失调、糖酵解增强和HIF-1信号通路激活。
Heliyon. 2023 Mar 27;9(4):e14949. doi: 10.1016/j.heliyon.2023.e14949. eCollection 2023 Apr.
9
GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL.GALNT2 通过 AXL 促进结直肠癌细胞的侵袭。
Mol Oncol. 2023 Jan;17(1):119-133. doi: 10.1002/1878-0261.13347. Epub 2022 Dec 5.
10
Multi-omics analysis reveals neuroinflammation, activated glial signaling, and dysregulated synaptic signaling and metabolism in the hippocampus of aged mice.多组学分析揭示了老年小鼠海马体中的神经炎症、激活的胶质细胞信号传导以及失调的突触信号传导和代谢。
Front Aging Neurosci. 2022 Nov 3;14:964429. doi: 10.3389/fnagi.2022.964429. eCollection 2022.
靶向AXL受体酪氨酸激酶降解以克服吉非替尼耐药的非小细胞肺癌中的耐药性。
Oncotarget. 2015 Apr 30;6(12):10146-60. doi: 10.18632/oncotarget.3380.
4
The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.TAM 家族:磷脂酰丝氨酸感知受体酪氨酸激酶在癌症中的失常。
Nat Rev Cancer. 2014 Dec;14(12):769-85. doi: 10.1038/nrc3847.
5
Axl as a mediator of cellular growth and survival.Axl作为细胞生长和存活的介质。
Oncotarget. 2014 Oct 15;5(19):8818-52. doi: 10.18632/oncotarget.2422.
6
AXL kinase as a novel target for cancer therapy.AXL激酶作为癌症治疗的新靶点。
Oncotarget. 2014 Oct 30;5(20):9546-63. doi: 10.18632/oncotarget.2542.
7
Diversification of TAM receptor tyrosine kinase function.TAM 受体酪氨酸激酶功能的多样化。
Nat Immunol. 2014 Oct;15(10):920-8. doi: 10.1038/ni.2986. Epub 2014 Sep 7.
8
AXL mediates resistance to cetuximab therapy.AXL介导对西妥昔单抗治疗的耐药性。
Cancer Res. 2014 Sep 15;74(18):5152-64. doi: 10.1158/0008-5472.CAN-14-0294. Epub 2014 Aug 18.
9
Identification and mutagenesis of the TACE and γ-secretase cleavage sites in the colony-stimulating factor 1 receptor.鉴定和突变集落刺激因子 1 受体中的 TACE 和 γ-分泌酶切割位点。
Biochem Biophys Res Commun. 2014 Jul 18;450(1):782-7. doi: 10.1016/j.bbrc.2014.06.061. Epub 2014 Jun 21.
10
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.E3 连接酶 Cbl-b 和 TAM 受体通过自然杀伤细胞调节癌症转移。
Nature. 2014 Mar 27;507(7493):508-12. doi: 10.1038/nature12998. Epub 2014 Feb 19.